iXpressGenes, Inc.
iXpressGenes is a biotechnology company dedicated to transforming trauma care through innovative, science-driven solutions. Their mission is to bridge the gap between mental and physical health by detecting and addressing trauma-induced conditions before symptoms emerge. Leveraging advanced RNA biomarker technology, iXpressGenes empowers healthcare providers to deliver proactive, data-driven care that prevents long-term suffering and improves patient outcomes. The company is committed to early detection, prevention, and the development of tools that legitimize the biological realities of trauma, ultimately redefining the future of trauma care.
Industries
Nr. of Employees
small (1-50)
iXpressGenes, Inc.
601 Genome Way NW Suite 2023, Huntsville, AL 35806
Products
Blood-based transcriptomic diagnostic test (trauma biomarker panel)
A laboratory diagnostic test that measures a validated panel of blood RNA biomarkers to detect dysregulated immune and neuro-inflammatory signals associated with trauma-related disease risk and to provide actionable clinical severity information.
High-performance DNA polymerase reagent
Engineered nucleic-acid amplification reagent optimized for pathogen detection and diagnostic applications.
Environmental DNA library and metagenomic discovery platform
A rare environmental DNA library constructed from extremophilic samples for metagenomic screening and discovery of novel bioactive compounds, including antibiotics.
Blood-based transcriptomic diagnostic test (trauma biomarker panel)
A laboratory diagnostic test that measures a validated panel of blood RNA biomarkers to detect dysregulated immune and neuro-inflammatory signals associated with trauma-related disease risk and to provide actionable clinical severity information.
High-performance DNA polymerase reagent
Engineered nucleic-acid amplification reagent optimized for pathogen detection and diagnostic applications.
Environmental DNA library and metagenomic discovery platform
A rare environmental DNA library constructed from extremophilic samples for metagenomic screening and discovery of novel bioactive compounds, including antibiotics.
Services
Laboratory testing service that analyzes blood RNA to detect immune and neuro-inflammatory signatures associated with trauma and to provide severity and monitoring outputs for clinicians.
Educational programs and resources for clinicians to interpret biomarker results, integrate testing into practice workflows, and use results to guide treatment plans.
Collaborative support to incorporate biomarker testing into clinical studies and programs, including partnerships with nonprofits and healthcare systems.
Laboratory testing service that analyzes blood RNA to detect immune and neuro-inflammatory signatures associated with trauma and to provide severity and monitoring outputs for clinicians.
Educational programs and resources for clinicians to interpret biomarker results, integrate testing into practice workflows, and use results to guide treatment plans.
Collaborative support to incorporate biomarker testing into clinical studies and programs, including partnerships with nonprofits and healthcare systems.
Expertise Areas
- Trauma-focused biomarker diagnostics
- RNA transcriptomics and gene expression analysis
- Molecular diagnostic assay development
- Clinical trial collaboration and implementation
Key Technologies
- RNA sequencing (RNA-seq)
- Gene expression biomarker panels
- Blood-based transcriptomic assays
- Nucleic-acid amplification and polymerase engineering
News & Updates
iXG has developed a first-of-its-kind blood test to detect trauma-related inflammation, marking a major step forward in PTSD screening and early intervention.
Nonprofit Kids to Love and iXpressGenes launched a groundbreaking PTSD clinical trial combining therapy with a blood-based inflammation test—believed to be the first of its kind in the nation.
Kids to Love is partnering with iXpressGenes in a new clinical trial aimed at addressing PTSD through bloodwork and therapy.
WellStone, the largest mental health provider in North Alabama, has ordered several hundred Trauma Autoimmune Indicator tests from iXpressGenes to enhance trauma screening.
Fifteen years after the mass shooting at the University of Alabama in Huntsville, a survivor turns that bloodshed into a blood test.
The city of Huntsville experienced a tragedy in 2010, which led to iXpressGenes pioneering PTSD identification and treatment.
iXG has developed a first-of-its-kind blood test to detect trauma-related inflammation, marking a major step forward in PTSD screening and early intervention.
Nonprofit Kids to Love and iXpressGenes launched a groundbreaking PTSD clinical trial combining therapy with a blood-based inflammation test—believed to be the first of its kind in the nation.
Kids to Love is partnering with iXpressGenes in a new clinical trial aimed at addressing PTSD through bloodwork and therapy.
WellStone, the largest mental health provider in North Alabama, has ordered several hundred Trauma Autoimmune Indicator tests from iXpressGenes to enhance trauma screening.
Fifteen years after the mass shooting at the University of Alabama in Huntsville, a survivor turns that bloodshed into a blood test.
The city of Huntsville experienced a tragedy in 2010, which led to iXpressGenes pioneering PTSD identification and treatment.